Excess Mortality Associated With Colistin-Tigecycline Compared With Colistin-Carbapenem Combination Therapy for Extensively Drug-Resistant Acinetobacter baumannii Bacteremia: A Multicenter Prospective Observational Study

Critical Care Medicine
Aristine ChengShan-Chwen Chang

Abstract

Since few therapeutic options exist for extensively drug resistant Acinetobacter baumannii, an emerging threat in ICUs worldwide, and comparative prospective studies of colistin-based combination therapies are lacking, our objective was to compare the outcomes of patients with extensively drug-resistant A. baumannii bacteremia, treated with colistin-carbapenem and colistin-tigecycline combinations. Prospective, observational, multicenter study. Adults with extensively drug-resistant A. baumannii bacteremia were prospectively followed from 2010 to 2013 at three hospitals in Taiwan. Extensively drug-resistant A. baumannii was defined as A. baumannii (genospecies 2) nonsusceptible to all drug classes except for colistin and tigecycline, and standard combination therapy as use of parenteral colistin-carbapenem or colistin-tigecycline for at least 48 hours after onset of bacteremia. Primary outcome measure was 14-day mortality. Of the 176 episodes of extensively drug-resistant A. baumannii bacteremia evaluated, 55 patients with a median (interquartile range) age of 62 years (44-79 yr) and Sequential Organ Failure Assessment score of 9 (5-13) points received standard combination therapy: colistin-tigecycline in 29 patients and colist...Continue Reading

References

Jan 12, 2005·BMC Infectious Diseases·Matthew E FalagasArgyris Michalopoulos
Aug 5, 2005·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Gary A Noskin
Jul 14, 2006·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Gary E Stein, William A Craig
Aug 31, 2006·Antimicrobial Agents and Chemotherapy·Jian LiLisa Liolios
Mar 14, 2007·The Journal of Antimicrobial Chemotherapy·Shiri Navon-VeneziaYehuda Carmeli
Jul 25, 2007·Antimicrobial Agents and Chemotherapy·Federico PerezRobert A Bonomo
Aug 9, 2007·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Jian LiClare Franklin
Oct 24, 2007·Antimicrobial Agents and Chemotherapy·Joshua S HawleyJames H Jorgensen
Jan 18, 2008·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Kara B AnthonyEbbing Lautenbach
May 1, 2008·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Lisa L Maragakis, Trish M Perl
Oct 11, 2008·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·N PetrosilloM E Falagas
Nov 22, 2008·The Lancet Infectious Diseases·Drosos E Karageorgopoulos, Matthew E Falagas
Nov 28, 2009·The Journal of Antibiotics·Murat DizbayDilek Arman
Dec 23, 2009·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·David GardinerTimothy Babinchak
May 14, 2010·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·D M SengstockK S Kaye
Jul 28, 2010·Antimicrobial Agents and Chemotherapy·C Andrew DerykeMark R Wallace
Jan 5, 2011·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Yu-Chung ChuangShan-Chwen Chang
Jun 21, 2011·The Journal of Antimicrobial Chemotherapy·Dafna YahavLeonard Leibovici
Jul 29, 2011·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·A-P MagiorakosD L Monnet
Aug 24, 2011·Antimicrobial Agents and Chemotherapy·Krisztina M Papp-WallaceRobert A Bonomo
Sep 9, 2011·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Jason M PogueKeith S Kaye
Nov 19, 2011·Medicina clínica·Alicia Hernández-TorresGenoveva Yagüe
Mar 1, 2012·Antimicrobial Agents and Chemotherapy·Timothy P GauthierLaura B Smith
Mar 24, 2012·The Journal of Antimicrobial Chemotherapy·Yun CaiNan Bai
Apr 3, 2012·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Paritosh PrasadCharles Natanson
Apr 13, 2012·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Yi-Tzu LeeChang-Phone Fung
Jan 31, 2013·Intensive Care Medicine·R P DellingerUNKNOWN Surviving Sepsis Campaign Guidelines Committee including The Pediatric Subgroup
Jun 21, 2013·Critical Care Medicine·L Silvia Munoz-PriceYohei Doi
Jul 19, 2013·Critical Care Medicine·Brad Spellberg, Robert A Bonomo

❮ Previous
Next ❯

Citations

Sep 15, 2015·Expert Opinion on Drug Safety·Theodoros Kelesidis, Matthew E Falagas
Dec 10, 2015·Infectious Diseases and Therapy·Phillip J BergenBrian T Tsuji
May 28, 2016·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·N L ParchemC V Murphy
Jul 28, 2016·International Journal of Antimicrobial Agents·Gauri G RaoBrian T Tsuji
Jul 5, 2017·Antimicrobial Agents and Chemotherapy·Yi-Tzu LeeYa-Sung Yang
Dec 16, 2016·Clinical Microbiology Reviews·Darren WongBrad Spellberg
Jan 14, 2020·Protein Science : a Publication of the Protein Society·Logan M TilleryWesley C Van Voorhis
Jan 23, 2020·Journal of Clinical Medicine·Shio-Shin JeanChin-Wan Hsu
Jan 16, 2020·Journal of Clinical Medicine·Yung-Chih WangAnd Yi-Tzu Lee
May 16, 2015·Critical Care Medicine·Brad Spellberg, Robert A Bonomo
Jan 15, 2020·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·Diamantis P KofteridisAntonis Valachis
Mar 6, 2017·Infectious Diseases and Therapy·Eric WenzlerEllie J C Goldstein
Oct 16, 2015·Critical Care Medicine·Gennaro De Pascale, Massimo Antonelli
Nov 12, 2019·Antimicrobial Resistance and Infection Control·Sarah Melissa NørgaardAlma Becic Pedersen
Sep 17, 2015·Critical Care Medicine·Garyphallia PoulakouSotirios Tsiodras
Aug 24, 2016·Current Opinion in Critical Care·Nina M ClarkJoseph P Lynch
Sep 15, 2017·Bioscience Trends·Yun YuShuming Pan
Jul 7, 2017·Critical Care : the Official Journal of the Critical Care Forum·Gennaro De PascaleMassimo Antonelli
Jan 13, 2017·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·L Lapointe-ShawA McGeer
Feb 23, 2019·Frontiers in Microbiology·Jetsi Mancilla-RojanoAriadnna Cruz-Córdova
Apr 7, 2017·Annals of Clinical Microbiology and Antimicrobials·Jian WangYuanhong Xu
Dec 29, 2020·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·Florian WagenlehnerJason M Pogue
Jun 20, 2018·Deutsches Ärzteblatt International·Moritz FritzenwankerTrinad Chakraborty

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Carbapenems (ASM)

Carbapenems are members of the beta lactam class of antibiotics and are used for the treatment of severe or high-risk bacterial infections. Discover the latest research on carbapenems here.

Carbapenems

Carbapenems are members of the beta lactam class of antibiotics and are used for the treatment of severe or high-risk bacterial infections. Discover the latest research on carbapenems here.

Acinetobacter Infections

Acinetobacter infections have become common in hospitalized patients, especially in the intensive care unit setting and are difficult to treat due to their propensity to develop antimicrobial drug resistance. Discover the latest research on Acinetobacter Infections here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Related Papers

European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology
Ayse BatirelHava Yilmaz
Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America
Tat Ming NgA Apisarnthanarak
Emerging Infectious Diseases
Yohei DoiDavid L Paterson
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
David B HuangTom Chiang
© 2021 Meta ULC. All rights reserved